In Depth 18 Jul 2025 Hyderabad’s Genome Valley, biopharma’s scale-up hub Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy. July 18, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 18 Jul 2025Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy This week, I talked to Niels Riedemann, CEO and Founder of InflaRx, about his company’s first-in-class approach to fighting inflammation. July 18, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 17 Jul 2025 New horizons in sickle cell disease treatment: Promising therapies on the way Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease. July 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 16 Jul 2025 Eight rare autoimmune diseases biotechs are fighting to treat Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them. July 16, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jul 2025 Serial acquirer Concentra Biosciences on a buyout spree in 2025 Concentra Biosciences is buying struggling biotechs and its portfolio has been growing rapidly in 2025. Learn about what it has been up to this past year. July 15, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Jul 2025 Top biotech books of all time Here are 51 great biotech books for this summer 2025 that are bound to get you hooked. From sci-fi to the nitty-gritties of biotech, we’ve got you covered! July 14, 2025 - 25 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2025 XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? Turnstone Biologics is being acquired by royalty aggregator Xoma Royalty. Discover how royalty deals are shaping the biopharma industry. July 11, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 11 Jul 2025How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder This week we talk about Congenital Adrenal Hyperplasia and how OMass Therapeutics is approaching it with the company CEO, Ros Deegan. July 11, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 10 Jul 2025 Radiopharma’s new wave: Nuclidium and Actithera raise the stakes Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms. July 10, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Jul 2025 New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. July 9, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 8 Jul 2025 The biggest biotech funding rounds in June 2025 The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June 2025. July 8, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Jul 2025 Biotech in Vienna: a budding life science hub As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years. July 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email